Senior insider sale
CMO & Head of Development at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$134.4K
10.83K shares
What this filing means
WATKINS TIM plans to sell 10.83K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $134.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001950047-25-010732
Officer· CMO & Head of Development
Since Mar 2026
10.83K
Shares to sell
$134.4K
Approx. market value
10.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/29/2025
10.83KTotal acquired10.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/29/2025 | Exercise of Stock Options Cash | 10.83K | — |
| Total | 10.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10.83K
Market value
$134.4K
12/29/2025
Total
Units
10.83K
Value
$134.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/29/2025 | 10.83K | $134.4K | NASDAQ | Planned |
| Total | 10.83K | $134.4K | ||